Search results
Regeneron (REGN) Announces Positive Data on Oncology Candidate
Zacks via Yahoo Finance· 2 hours agoRegeneron's (REGN) REGN7075, in combination with its oncology drug Libtayo, generates anti-tumor...
ASCO: With hopes high, Regeneron misses mark with just 1 complete response in solid tumor trial so...
FierceBiotech· 18 hours agoRegeneron’s costimulatory bispecific antibody REGN7075 is being tested in patients with advanced...
US pharma giant Cencora says Americans' health information stolen in data breach
TechCrunch· 2 hours agoU.S. pharmaceutical giant Cencora says it is notifying affected individuals that their personal and...
Dynamic Technology Lab Private Ltd Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 1 day agoDynamic Technology Lab Private Ltd purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company ...
Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Trading At A 48% Discount?
Simply Wall St. via Yahoo Finance· 2 days agoKey Insights Regeneron Pharmaceuticals' estimated fair value is US$1,903 based on 2 Stage Free Cash...
Ireland – the jewel in the life sciences crown?
Medical Device Network via Yahoo Finance· 1 hour agoBiotech boom One of the country’s leading success stories is Regeneron, which has earned recognition as one of the Best Workplaces in Ireland. Originally...
Regeneron Files Second BPCIA Complaint Against Celltrion’s Proposed EYLEA® Biosimilar CT-P42 | JD...
JD Supra· 1 day agoOn May 17, 2024, Regeneron filed a second infringement litigation against Celltrion’s proposed EYLEA® (aflibercept) biosimilar CT-P42, Case No....
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 18 hours agoRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive new results from an ongoing Phase 1/2 trial evaluating its first-in-class costimulatory bispecific ...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Regeneron...
NBC 10 - FOX 14 Monroe· 2 days agoPomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN). Such investors ...
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
Motley Fool via Yahoo Finance· 1 day agoNvidia (NASDAQ: NVDA), Netflix (NASDAQ: NFLX), and Regeneron Pharmaceuticals (NASDAQ: REGN) have...
